185 related articles for article (PubMed ID: 22681159)
1. Rapid identification of yeast by fluorescence in situ hybridisation from broth and blood cultures.
Frickmann H; Lakner A; Essig A; Poppert S
Mycoses; 2012 Nov; 55(6):521-31. PubMed ID: 22681159
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fluorescence in situ hybridisation (FISH) for the identification of Candida albicans in comparison with three phenotypic methods.
Lakner A; Essig A; Frickmann H; Poppert S
Mycoses; 2012 May; 55(3):e114-23. PubMed ID: 22126597
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three differential media for the presumptive identification of yeasts.
Yucesoy M; Ozbek OA; Marol S
Clin Microbiol Infect; 2005 Mar; 11(3):245-7. PubMed ID: 15715727
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method in the identifi cation of Candida species isolated from blood cultures].
Aydemir G; Koç AN; Atalay MA
Mikrobiyol Bul; 2016 Apr; 50(2):293-9. PubMed ID: 27175502
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of methods for the identification of the most common yeasts in the clinical microbiology laboratory].
Guelfand L; Grisolía P; Bozzano C; Kaufman S
Rev Argent Microbiol; 2003; 35(1):49-53. PubMed ID: 12833681
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis and epidemiology of fungal infections.
Reiss E; Tanaka K; Bruker G; Chazalet V; Coleman D; Debeaupuis JP; Hanazawa R; Latgé JP; Lortholary J; Makimura K; Morrison CJ; Murayama SY; Naoe S; Paris S; Sarfati J; Shibuya K; Sullivan D; Uchida K; Yamaguchi H
Med Mycol; 1998; 36 Suppl 1():249-57. PubMed ID: 9988514
[TBL] [Abstract][Full Text] [Related]
7. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of PNA-FISH method for direct identification of Candida species in blood culture samples and its potential impact on guidance of antifungal therapy].
Doğan Ö; İnkaya AÇ; Gülmez D; Uzun Ö; Akova M; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Oct; 50(4):580-589. PubMed ID: 28124963
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples].
Gayibova Ü; Dalyan Cılo B; Ağca H; Ener B
Mikrobiyol Bul; 2014 Jul; 48(3):438-48. PubMed ID: 25052110
[TBL] [Abstract][Full Text] [Related]
10. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
Sangorrín MP; Lopes CA; Rivero A; Caballero AC
Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species.
Ghelardi E; Pichierri G; Castagna B; Barnini S; Tavanti A; Campa M
Clin Microbiol Infect; 2008 Feb; 14(2):141-7. PubMed ID: 17986267
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of different methods for the identification of Candida species isolated from clinical specimens].
Cetinkaya Z; Altindiş M; Aktepe OC; Karabiçak N
Mikrobiyol Bul; 2003 Oct; 37(4):269-76. PubMed ID: 14748264
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of Candida species and other clinically important yeast species by flow cytometry.
Page BT; Kurtzman CP
J Clin Microbiol; 2005 Sep; 43(9):4507-14. PubMed ID: 16145099
[TBL] [Abstract][Full Text] [Related]
14. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the significance of molecular methods in the diagnosis of invasive fungal infections: comparison with conventional methods].
Susever S; Yeğenoğlu Y
Mikrobiyol Bul; 2011 Apr; 45(2):325-35. PubMed ID: 21644076
[TBL] [Abstract][Full Text] [Related]
16. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
17. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
18. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.
Abdelhamed AM; Zhang SX; Watkins T; Morgan MA; Wu F; Buckner RJ; Fuller DD; Davis TE; Salimnia H; Fairfax MR; Lephart PR; Poulter MD; Regi SB; Jacobs MR
J Clin Microbiol; 2015 May; 53(5):1672-6. PubMed ID: 25762766
[TBL] [Abstract][Full Text] [Related]
20. Rapid differentiation of Candida albicans from non-C. albicans directly in a variety of clinical specimens using fluorescent in situ hybridisation.
Wang P
Mycoses; 2011 Jul; 54(4):331-6. PubMed ID: 20070532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
